Finerenone, Sotagliflozin Benefit HF Despite Renal Dysfunction Finerenone, Sotagliflozin Benefit HF Despite Renal Dysfunction

New analyses from clinical trials of these cardiorenal agents showed consistent heart failure benefit across the broad spectrum of renal function, including severe dysfunction.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news